在老年成人患者中,侵袭性对保守管理与非ST段升高心肌梗塞:随机对照试验的元分析.
Mohamed Hamed1, El-Moatasem Gabr2, Wissam Harmouch3
1Division of Cardiology Florida Atlantic University Boca Raton FL USA.
Journal of the American Heart Association
|July 14, 2025
概括
对于患有非ST段升高心肌梗塞 (NSTEMI) 的老年人,侵入性治疗没有显示出存活率差异,但减少了复发性心脏病发作和再血管化需求. 这有助于老年NSTEMI患者的治疗决策.
科学领域:
- 心脏病学 心脏病学
- 老年医学 老年医学
- 临床试验 临床试验
背景情况:
- 在NSTEMI管理试验中,老年人代表性不足.
- 关键试验往往缺乏足够的关于老年NSTEMI患者的数据.
研究的目的:
- 为了在70岁及以上的患者中比较NSTEMI的侵入性与保守性治疗.
- 评估包括死亡率,主要心脏不良事件和出血风险在内的结果.
主要方法:
- 随机对照试验的系统审查和元分析.
- 在MEDLINE,Embase和Cochrane数据库中搜索到2024年9月.
- 包括7个RCT,包括2997名年龄≥70岁的患者.
主要成果:
- 在所有原因的死亡率上没有显著差异 (27.9%与26.6%).
- 侵袭性方法显示,主要不良心脏事件减少的趋势 (28.3%与33.4%相比).
- 侵入性治疗减少了复发性心肌梗塞和缺血驱动的重血管化,而没有增加大出血.
结论:
- 在患有NSTEMI的老年人中,入侵和保守的方法具有相似的生存率.
- 侵入性策略降低了复发性心脏病发作和再血管化的风险,而不会增加出血风险.
- 研究结果支持老年NSTEMI患者在治疗策略方面做出明智的决策.
更多相关视频
09:21Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.1K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.7K
相关概念视频
Angina IV: Management
27
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
27
Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Angina V: Nursing Management
53
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
53
Mitral Stenosis III: Medical Management
27
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
27
Myocarditis III: Medical Management
17
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
17
Atherosclerosis III: Management
40
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
40
